Breaking News Instant updates and real-time market news.

GORO

Gold Resource

$5.23

-0.06 (-1.13%)

, CLIR

ClearSign Combustion

$2.15

(0.00%)

08:50
08/29/18
08/29
08:50
08/29/18
08:50

Three Part Advisors to hold a conference

Midwest Ideas Investor Conference will be held in Chicago on August 29-30 with webcasted company presentations to begin on August 29 at 9 am; not all company presentations may be webcasted. Webcast Link

GORO

Gold Resource

$5.23

-0.06 (-1.13%)

CLIR

ClearSign Combustion

$2.15

(0.00%)

CRAI

CRA International

$57.99

0.24 (0.42%)

PCTI

PCTEL

$4.37

0.11 (2.58%)

ECHO

Echo Global

$33.20

-0.45 (-1.34%)

EBS

Emergent BioSolutions

$61.56

0.35 (0.57%)

HWCC

Houston Wire & Cable

$8.50

(0.00%)

TOWR

Tower International

$35.20

0.15 (0.43%)

TREC

Trecora Resources

$14.10

0.1 (0.71%)

HCKT

Hackett Group

$20.16

-0.13 (-0.64%)

PRIM

Primoris

$24.96

-0.05 (-0.20%)

UFPT

UFP Technologies

$35.65

-0.95 (-2.60%)

CMO

Capstead Mortgage

$8.38

0.02 (0.24%)

GRBK

Green Brick

$10.15

-0.15 (-1.46%)

INTL

INTL FCStone

$56.28

0.15 (0.27%)

KEYW

KEYW

$8.23

0.11 (1.35%)

INWK

InnerWorkings

$7.62

0.1 (1.33%)

CUBI

Customers Bancorp

$24.62

-0.28 (-1.12%)

DSPG

DSP Group

$12.95

0.1 (0.78%)

TIPT

Tiptree Financial

$6.48

-0.05 (-0.77%)

PCYO

Pure Cycle

$10.90

-0.3 (-2.68%)

TLRA

Telaria

$3.63

0.045 (1.26%)

EDUC

Educational Development Corp.

$12.50

-0.1 (-0.79%)

SHLO

Shiloh Industries

$9.17

-0.04 (-0.43%)

ACCO

ACCO Brands

$12.50

-0.05 (-0.40%)

  • 29

    Aug

  • 05

    Sep

  • 05

    Sep

  • 06

    Sep

  • 06

    Sep

  • 11

    Sep

  • 12

    Sep

  • 13

    Sep

  • 18

    Sep

  • 27

    Sep

  • 27

    Sep

  • 28

    Sep

  • 01

    Oct

  • 06

    Nov

GORO Gold Resource
$5.23

-0.06 (-1.13%)

CLIR ClearSign Combustion
$2.15

(0.00%)

CRAI CRA International
$57.99

0.24 (0.42%)

PCTI PCTEL
$4.37

0.11 (2.58%)

08/09/18
LSCM
08/09/18
DOWNGRADE
LSCM
Hold
PCTEL downgraded to Hold from Buy at Lake Street
08/09/18
LSCM
08/09/18
DOWNGRADE
Target $6
LSCM
Hold
PCTEL downgraded to Hold with $6 target at Lake Street
Lake Street analyst Jaeson Schmidt downgraded PCTE to Hold from Buy and lowered his price target for the shares to $6 from $9. The company's Q3 outlook and the downward adjustment to full year guidance came in well below estimates as it is seeing meaningful headwinds in both of its business segments, Schmidt tells investors in a post-earnings research note. He finds it prudent to move to the sidelines until visibility improves. B. Riley FBR also downgraded PCTEL this morning.
08/09/18
RILY
08/09/18
DOWNGRADE
Target $4.5
RILY
Neutral
PCTEL downgraded to Neutral from Buy at B. Riley FBR
B. Riley FBR analyst Mike Crawford downgraded PCTEL to Neutral and lowered his price target for the shares to $4.50 from $8.50. The analyst sees the challenges that drove the reduced fiscal 2018 guidance persisting for the remainder of the year.
ECHO Echo Global
$33.20

-0.45 (-1.34%)

02/23/18
02/23/18
DOWNGRADE
Target $20

Underweight
Echo Global downgraded to Underweight at Morgan Stanley
As previously reported, Morgan Stanley analyst Ravi Shanker downgraded Echo Global to Underweight from Equal Weight, as he believes brokers like Echo deserve a "mid-teens multiple at best" as he thinks the mandate for electronic logging devices, or ELDs, will present a challenge to all brokers. Though Echo's high spot exposure may leave it somewhat better positioned than contract exposed peers, Shanker sees this as more than priced into the stock, he tells investors, adding that the market appears to be significantly underestimating the risk of shippers reducing their reliance on brokers altogether in 2018. Due largely to a 20% EPS increase from tax reform, Shanker increased his price target on Echo shares to $20 from $15.
06/19/18
STFL
06/19/18
INITIATION
Target $34
STFL
Buy
Echo Global resumed with a Buy at Stifel
Stifel analyst J. Bruce Chan resumed coverage of Echo Global with a Buy rating and $34 price target.
04/26/18
BRRR
04/26/18
NO CHANGE
BRRR
Echo Global price target raised to $37 from $35 at Barrington
Barrington analyst Kevin Steinke reiterated his Outperform rating on Echo Global and raised his price target to $37 from $35 following the company's Q1 results, that were well ahead of the firm's estimates, as well as management's commentary that "the current solid demand environment appears to be sustainable due to continued robust freight demand and supply constraints on truckload capacity."
02/23/18
02/23/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. UPS (UPS) downgraded to Hold from Buy at Deutsche Bank with analyst Amit Mehrotra saying UPS's capex guidance was worse than even the most bearish expectations. 2. Echo Global (ECHO) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Ravi Shanker saying he believes brokers like Echo deserve a "mid-teens multiple at best" as he thinks the mandate for electronic logging devices, or ELDs, will present a challenge to all brokers. 3. Ardagh Group (ARD) downgraded to Market Perform from Outperform at Wells Fargo with analyst Christopher Manuel saying he analyst now sees "limited capital redeployment options" for Ardagh over the next 24-36 months. 4. Acacia Communications (ACIA) downgraded to Neutral from Buy at MKM Partners and to Hold from Buy at DA Davidson and Needham. 5. Aegean Marine (ANW) downgraded to Hold from Buy at Stifel with analyst Benjamin Nolan saying the company's deal to buy the parent company of Hellenic Environmental Centers "takes the cake" in terms of questionable deals, adding "it is hard to even fathom how any transaction could possibly be worse." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
EBS Emergent BioSolutions
$61.56

0.35 (0.57%)

08/29/18
CANT
08/29/18
NO CHANGE
Target $62
CANT
Overweight
Emergent acquisition should bridge guidance gap, says Cantor Fitzgerald
Cantor Fitzgerald analyst Brandon Folkes believes Emergent BioSolutions' acquisition of Adapt Pharma and its opioid overdose product, Narcan nasal spray, should help "bridge the Street's gap" from the current 2020 consensus revenue estimate of $830M to the company's guidance of $1B. The analyst keeps an Overweight rating on Emergent with a $62 price target.
08/10/18
WELS
08/10/18
NO CHANGE
Target $61
WELS
Market Perform
Emergent BioSolutions acquisition of PaxVax an 'excellent fit,' says Wells Fargo
After Emergent BioSolutions agreed to acquire PaxVax for $270M, Wells Fargo analyst David Maris said the transaction "sounds as though it is an excellent fit" and he is adding $70M in revenues for 2019 and assuming growth of 10% per year, though he thinks that could be conservative given the possible sales synergies. He also raised his price target on Emergent BioSolutions shares to $61 from $56, though he keeps a Market Perform rating on the shares.
08/29/18
CANT
08/29/18
NO CHANGE
Target $32
CANT
Overweight
Cantor sees value in Opiant after Emergent acquires Adapt Pharma
Cantor Fitzgerald analyst Brandon Folkes believes Emergent BioSolutions' (EBS) acquisition of Adapt Pharma underscores the potential for companies addressing the opioid overdose market. Opiant Pharmaceuticals (OPNT) is developing its own opioid overdose nasal spray, OPNT003, which could be of benefit in cases of synthetic opioid overdoses, such as with fentanyl, Folkes tells investors in a research note. He believes Opiant presents an attractive risk/reward at current share levels, "even if it captures only a portion of the growing market opioid overdose market." Folkes keeps an Overweight rating on the shares with a $32 price target.
06/13/18
06/13/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Liberty Global (LBTYA) initiated with a Sell at Berenberg. 2. Emergent BioSolutions (EBS) initiated with a Buy at Argus. 3. Nine Energy Services (NINE) initiated with a Strong Buy at Raymond James. 4. Can-Fite BioPharma (CANF) assumed with a Buy at H.C. Wainwright. 5. Control4 (CTRL) initiated with a Buy at Roth Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
HWCC Houston Wire & Cable
$8.50

(0.00%)

TOWR Tower International
$35.20

0.15 (0.43%)

02/14/18
RILY
02/14/18
NO CHANGE
Target $40
RILY
Buy
Tower selloff brings attractive entry point, says B. Riley FBR
B. Riley FBR analyst Christopher Van Horn believes the post-quarter selloff in shares of Tower International brings an attractive entry point. The analyst keeps a Buy rating on the shares with a $40 price target.
05/24/18
ROTH
05/24/18
INITIATION
Target $41
ROTH
Buy
Tower International initiated with a Buy at Roth Capital
Roth Capital analyst Matt Koranda started Tower International with a Buy rating and $41 price target saying it boasts a "solid" 2018/2019 growth outlook and has underappreciated exposure to the long-term secular tailwinds of OEM outsourcing and vehicle light-weighting.
08/28/18
WELS
08/28/18
NO CHANGE
WELS
Tentative U.S./Mexico trade deal a starting point for auto stock recovery, says Wells Fargo
Wells Fargo analyst Richard Kwas believes the U.S./Mexico tentative trade deal is a positive for the automotive space in the interim. In his view, part of the recent underperformance has come from trade uncertainty. NA centric supplier names like Magna (MGA) and Tower International (TOWR) could be the biggest beneficiaries. MGA does have material revenue exposure to Canada and therefore the absence of Canada in a final agreement would create some level of complication for the company relative to the rest of supplier group, he notes. Kwas believes the decision to limit non Mexico/U.S. content to 25% of vehicle value coupled with the 40%-45% minimum threshold for $16/hour manufacturing jobs should stabilize or increase U.S. share of vehicle production.
TREC Trecora Resources
$14.10

0.1 (0.71%)

HCKT Hackett Group
$20.16

-0.13 (-0.64%)

12/14/17
BRRR
12/14/17
NO CHANGE
Target $22
BRRR
Outperform
Hackett Group shares at attractive entry point, says Barrington
Barrington analyst Vincent Colicchio believes shares of Hackett Group are trading at an attractive entry point. The recovery of the Oracle business in 2018 should put the company back on track to achieve management's annual financial objectives, Colicchio tells investors in a research note. He views the current valuation as compelling given the company's better growth prospects next year. The analyst has an Outperform rating on Hackett with a $22 price target.
11/09/17
ROTH
11/09/17
UPGRADE
ROTH
Buy
Hackett Group upgraded to Buy from Neutral at Roth Capital
Roth Capital analyst Jeff Martin upgraded Hackett Group to Buy from Neutral and raised his price target to $20 from $16 after the company reported third quarter results at the high end of guidance that beat estimates. Martin said the premise of the upgrade was Hackett Group being able to return to favorable comparisons in the first quarter of 2018.
06/21/18
BRRR
06/21/18
NO CHANGE
Target $22
BRRR
Outperform
Hackett Group trades at attractive entry point, says Barrington
Barrington analyst Vincent Colicchio says Hackett Group shares, trading at a 40% discount to the peer group average, offer an attractive entry point. He expects revenue and non-GAAP earnings growth of 5% and 11% in 2018, respectively, better than growth of 1% and 6% in 2017 on an improvement in the Oracle business and a greater intellectual property contribution. The analyst keeps an Outperform rating on Hackett Group with a $22 price target.
11/09/17
ROTH
11/09/17
UPGRADE
ROTH
Buy
Hackett Group upgraded to Buy from Neutral at Roth Capital
PRIM Primoris
$24.96

-0.05 (-0.20%)

06/22/18
DADA
06/22/18
NO CHANGE
Target $34
DADA
Buy
Primoris price target raised to $34 from $30 at DA Davidson
DA Davidson analyst Brent Thielman raised his price target on Primoris to $34 after holding talks with its management, saying he came away "increasingly bullish" about the company's prospects around the Willbros integration, pipeline and Gulf Coast industrial construction opportunities. Thielman adds that he is also positive on Primoris' bookings and backlog growth as well as its earnings upside beyond Q2 amid opportunities in the Power, Industrial, and Engineering markets. The analyst keeps his Buy rating on the stock.
04/11/18
ADAM
04/11/18
NO CHANGE
Target $30
ADAM
Buy
Primoris acquisition strategies expected to be strong, says Canaccord
Canaccord analyst Bobby Burleson hosted investors meetings for Primoris and noted they were mostly positive and supported his outlook for strong growth and the potential for upside to estimates. He believes the Willbros acquisition will get done and revenues and synergies should be strong, especially with respect to some of Willbros largest customers. Burleson reiterated his Buy rating and $30 price target on Primoris shares
03/29/18
KEYB
03/29/18
NO CHANGE
KEYB
Sector Weight
Primoris acquisition of Willbros Group 'compelling turnaround,' says KeyBanc
KeyBanc analyst Tahira Afzal views the Willbros Group (WG) acquisition by Primoris (PRIM) as presenting a "compelling turnaround/value creation opportunity." Furthermore, the analyst views deal dynamics as attractive from a valuation perspective, and initial assumptions for the Willbros Group contribution appear to be conservative. Afzal reiterates a Sector Weight rating on Primoris' shares.
02/28/18
SIDC
02/28/18
UPGRADE
SIDC
Buy
Primoris upgraded to Buy from Neutral at Sidoti
UFPT UFP Technologies
$35.65

-0.95 (-2.60%)

02/02/18
02/02/18
NO CHANGE

UFP Technologies acquires Dielectrics
UFP Technologies announced the acquisition of Dielectrics, Inc. Founded in 1954 and based in Chicopee, Massachusetts, Dielectrics is a leader in the design, development, and manufacture of medical devices using thermoplastic materials. Sales in 2017 were approximately $43 million.
CMO Capstead Mortgage
$8.38

0.02 (0.24%)

12/07/17
KBWI
12/07/17
UPGRADE
KBWI
Outperform
Capstead Mortgage upgraded to Outperform from Market Perform at Keefe Bruyette
07/09/18
KBWI
07/09/18
DOWNGRADE
Target $9
KBWI
Market Perform
Capstead downgraded to Market Perform from Outperform at Keefe Bruyette
Keefe Bruyette analyst Eric Hagen downgraded Capstead Mortgage to Market Perform and lowered his price target for the shares to $9.00 from $9.50. The analyst cites valuation for the downgrade and recommends a short-term underweight of the stock heading into earnings. A flatter yield curve will likely put additional downward pressure on Capstead's net interest margin, Hagen tells investors in a research note.
07/31/18
07/31/18
DOWNGRADE
Target $7.5

Underperform
Capstead Mortgage downgraded to Underperform with $7.50 target at JMP Securities
As previously reported, JMP Securities analyst Steven DeLaney downgraded Capstead Mortgage to Underperform from Market Perform and set a $7.50 price target on the shares after the company reported Q2 earnings that fell "far short" of consensus expectations. He also cited the fact that Capstead recently lowered its quarterly dividend rate to 14c from 16c. Though the stock already trades at a discount to the peer group in terms of price to book value, DeLaney thinks there is further downside risk, he tells investors.
07/31/18
JMPS
07/31/18
DOWNGRADE
JMPS
Underperform
Capstead Mortgage downgraded to Underperform at JMP Securities
GRBK Green Brick
$10.15

-0.15 (-1.46%)

08/09/18
SBSH
08/09/18
UPGRADE
Target $12
SBSH
Buy
Green Brick upgraded to Buy from Neutral at Citi
Citi analyst Scott Schrier upgraded Green Brick Partners to Buy and raised his price target for the shares to $12 from $11. The company posted "solid progress" with Q2 EBT and net orders above expectations, Schrier tells investors in a post-earnings research note. The analyst believes Green Brick is executing well in some of the best markets.
08/24/18
FBCO
08/24/18
INITIATION
Target $9
FBCO
Neutral
Green Brick initiated with a Neutral at Credit Suisse
Credit Suisse analyst Susan Maklari started Green Brick Partners with a Neutral rating and $9 price target. As supply constraints and inflation persist, the company's margins could be increasingly under pressure, Maklari tells investors in a research note. She believes the current valuation properly captures Green Brick's risk/reward profile.
06/19/18
SBSH
06/19/18
INITIATION
Target $13
SBSH
Neutral
Green Brick assumed with a Neutral at Citi
Citi analyst Scott Schrier assumed coverage of Green Brick Partners with a Neutral rating and $13 price target. The analyst took over coverage of the Building Products, Construction Materials group.
02/20/18
02/20/18
UPGRADE
Target $13

Outperform
Green Brick upgraded to Outperform at JMP Securities
As previously reported, JMP Securities analyst Peter Martin upgraded Green Brick to Outperform from Market Perform citing greater visibility on its Atlanta operations and growth prospects in Texas with its recent Frisco land acquisition. The analyst, who contends Green Brick shares are currently undervalued, set a $13 price target on the stock.
INTL INTL FCStone
$56.28

0.15 (0.27%)

KEYW KEYW
$8.23

0.11 (1.35%)

01/03/18
CHDN
01/03/18
DOWNGRADE
CHDN
Neutral
KEYW downgraded to Neutral from Buy at Chardan
Chardan analyst James McIlree downgraded KYEW to Neutral due to valuation saying it reflects the outlook of the company.
11/21/17
STFL
11/21/17
INITIATION
Target $6
STFL
Hold
KEYW initiated with a Hold at Stifel
Stifel analyst Joseph DeNardi initiated coverage of KEYW with a Hold rating and $6 price target.
08/01/18
DRXL
08/01/18
DOWNGRADE
DRXL
Hold
KEYW downgraded to Hold from Buy at Drexel Hamilton
Drexel Hamilton analyst Brian Ruttenbur downgraded KEYW to Hold from Buy saying the announced modification of one of its largest programs for flight services could be a 2019 headwind. Rutternbur said this contract contributes roughly $80M-100M annually and $10M- $15M of EBITDA and has concerns about growth.
INWK InnerWorkings
$7.62

0.1 (1.33%)

03/14/18
BRRR
03/14/18
NO CHANGE
Target $13
BRRR
Outperform
InnerWorkings undervalued after earnings selloff, says Barrington
Barrington analyst Kevin Steinke calls shares of InnerWorkings undervalued following the pullback on the company's Q4 results. While the quarter was "messy," the fundamental outlook remains solid, Steinke tells investors in a research note. He sees an attractive entry point for investors at current levels and keeps an Outperform rating on InnerWorkings with a $13 price target.
08/01/18
BRRR
08/01/18
DOWNGRADE
BRRR
Market Perform
InnerWorkings downgraded to Market Perform from Outperform at Barrington
08/01/18
08/01/18
DOWNGRADE

Market Perform
Barrington downgrades InnerWorkings to Market Perform after guidance withdrawn
As previously reported, Barrington analyst Kevin Steinke downgraded InnerWorkings to Market Perform from Outperform after the company reported Q1 results that were lower than expectations and withdrew its 2018 guidance. While the company said updated guidance is expected in a few weeks, management did state that it now expects 2018 profitability to be lower than 2017, noted Steinke, who also said the company's transformation plans may have long-term benefits but will potentially disrupt operations and performance in the near-term.
08/01/18
CHLM
08/01/18
DOWNGRADE
CHLM
Hold
InnerWorkings downgraded to Hold from Buy at Craig-Hallum
CUBI Customers Bancorp
$24.62

-0.28 (-1.12%)

10/20/17
BOSC
10/20/17
DOWNGRADE
BOSC
Neutral
Customers Bancorp downgraded to Neutral at Boenning & Scattergood
12/08/17
RILY
12/08/17
INITIATION
Target $35
RILY
Buy
Customers Bancorp resumed with a Buy at B. Riley FBR
B. Riley FBR resumed coverage of Customers Bancorp with a Buy rating and $35 price target.
02/14/18
DADA
02/14/18
INITIATION
Target $33
DADA
Neutral
Customers Bancorp initiated with a Neutral at DA Davidson
DA Davidson analyst Russell Gunther initiated Customers Bancorp with a price target of $33, saying the bank has grown organically at a 39% annual rate since its 2012 IPO. The analyst notes that following a write-down of Religare and spin-off of BankMobile in the second of half of this year. Customers Bancorp will "shine" and capture a "valuation re-rate" as its profitability ratios approach peer levels. Gunther keeps his Neutral rating, warning there is some uncertainty overhang around the timing of BankMobile spin-off.
02/14/18
02/14/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Hershey (HSY) reinstated with a Neutral at JPMorgan. 2. Customers Bancorp (CUBI) initiated with a Neutral at DA Davidson. 3. Restoration Robotics (HAIR) initiated with a Buy at Craig-Hallum. 4. Nuvectra (NVTR) initiated with an Outperform at JMP Securities. 5. Endo (ENDP) initiated with a Buy at B. Riley FBR. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
DSPG DSP Group
$12.95

0.1 (0.78%)

05/17/18
COWN
05/17/18
INITIATION
Target $15
COWN
Outperform
DSP Group initiated with an Outperform at Cowen
Cowen initiated DSP Group with an Outperform and $15 price target.
05/18/18
COWN
05/18/18
INITIATION
Target $15
COWN
Outperform
DSP Group initiated with an Outperform, $15 price target at Cowen
As reported previously, Cowen analyst Matthew Ramsay initiated DSP Group with an Outperform rating as he believes the company represents an under-the-radar turnaround story tied to secular trends of voice integration and low power connectivity proliferation in multiple applications. Ramsay has a $15 price target on DSP Group shares.
09/04/17
09/04/17
NO CHANGE

Libre Wireless using DSP Group SmartVoice technology
DSP Group announced that Libre Wireless Technologies is using DSP Group's SmartVoice technology for its industry leading fully integrated LS5BV LibreSync voice and media streaming module. The LS5BV module includes DSP Group's HDClear SoC with sophisticated algorithms for detecting and processing far field voice, including advanced noise reduction, echo cancellation, music barge-in and audio processing features. It is designed to support from 1 to 3 mics, giving customers flexibility for various applications that can be optimized for cost, front facing 180 or circular 360 degree applications. The LS5BV offers a clean interface to off-module mics allowing the product designer ultimate flexibility on mic placement and product integration while providing a simple low cost interface in a fully integrated mic-to-cloud voice solution. DSP Group's HDClear SoC is an innovative audio/voice SoC for IoT devices as smart speakers which enables far-field device activation and operation via voice commands while maintaining low power consumption and high performance using pre-process algorithms such as noise reduction, beam-forming and Acoustic Echo Canceling for barge-in mode using 1 to 3 mics.
TIPT Tiptree Financial
$6.48

-0.05 (-0.77%)

PCYO Pure Cycle
$10.90

-0.3 (-2.68%)

TLRA Telaria
$3.63

0.045 (1.26%)

03/20/18
LSCM
03/20/18
INITIATION
Target $7
LSCM
Buy
Telaria initiated with a Buy at Lake Street
Lake Street analyst Mark Argento started Telaria, formerly Tremor Video, with a Buy rating and $7 price target. In addition to having rebranded, Telaria has refocused its model over the last nine months into a fast-growing, standalone Supply Side Platform provider, which is a more attractive opportunity being overlooked by investors, Argento contends in his initiation note.
EDUC Educational Development Corp.
$12.50

-0.1 (-0.79%)

SHLO Shiloh Industries
$9.17

-0.04 (-0.43%)

09/07/17
BOFA
09/07/17
INITIATION
Target $9.5
BOFA
Neutral
Shiloh Industries initiated with a Neutral at BofA/Merrill
BofA/Merrill analyst John Murphy initiated Shiloh Industries with an Equal Weight and a $9.50 price target citing out sized risk of a downturn in the US auto cycle relative to more globally diversified suppliers.
ACCO ACCO Brands
$12.50

-0.05 (-0.40%)

02/15/18
BRRR
02/15/18
NO CHANGE
BRRR
ACCO Brands earnings, guidance beat expectations, says Barrington
Barrington analyst Kevin Steinke reiterated an Outperform rating and $16 price target on ACCO Brands after the company's Q4 results and guidance both came in ahead of expectations, and ACCO initiated a 6c per share quarterly dividend and authorized and additional $100M for share repurchases. Steinke believes ACCO will continue a "balanced approach to capital allocation that includes organic investments, debt reduction, acquisitions, dividends and share repurchases."
05/02/18
NBLE
05/02/18
INITIATION
Target $15
NBLE
Buy
ACCO Brands initiated with a Buy at Noble Financial
Noble Financial initiated ACCO Brands with a Buy and $15 price target saying shares are undervalued, combined with mangement's proven growth by acquisition model.
05/01/18
BWSF
05/01/18
NO CHANGE
Target $18
BWSF
Strong Buy
BWS 'highly positive' on ACCO Brands after Q1 results
BWS Financial analyst Hamed Khorsand says he's "highly positive" on shares of ACCO Brands following the company's Q1 results. He would be buyer of the shares at current levels and believes the investment story is "beginning to come together." The analyst keeps a Buy rating on ACCO Brands with an $18 price target.

TODAY'S FREE FLY STORIES

SGMS

Scientific Games

$26.45

0.15 (0.57%)

16:34
09/25/18
09/25
16:34
09/25/18
16:34
Hot Stocks
Scientific Games signs contract with Hard Rock International »

Scientific Games…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGLY

Digital Ally

$3.75

-0.275 (-6.83%)

16:33
09/25/18
09/25
16:33
09/25/18
16:33
Syndicate
Digital Ally files to sell common stock, no amount given »

Roth Capital Partners is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

R

Ryder

$72.75

-0.04 (-0.05%)

16:33
09/25/18
09/25
16:33
09/25/18
16:33
Hot Stocks
Ryder CFO Art Garcia to retire in April 2019 »

Ryder announced that Art…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

BZH

Beazer Homes

$11.08

-0.015 (-0.14%)

16:33
09/25/18
09/25
16:33
09/25/18
16:33
Hot Stocks
Beazer says Hurricane Florence will result in sales, closings shifting to FY19 »

Beazer Homes provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCO

Moody's

$172.88

-2.66 (-1.52%)

16:31
09/25/18
09/25
16:31
09/25/18
16:31
Hot Stocks
Moody's appoints Mona Breed as CIO »

Moody's announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 28

    Sep

  • 02

    Oct

  • 21

    Oct

FCFS

First Cash Financial

$83.03

0.625 (0.76%)

16:31
09/25/18
09/25
16:31
09/25/18
16:31
Hot Stocks
First Cash Financial announces move to Nasdaq from NYSE »

FirstCash announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 06

    Nov

OKE

Oneok

$68.44

0.565 (0.83%)

16:31
09/25/18
09/25
16:31
09/25/18
16:31
Hot Stocks
Oneok to construct additional NGL fractionation, pipeline capacity »

Oneok announced plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
09/25/18
09/25
16:30
09/25/18
16:30
Options
Preliminary option volume of 15.6M today »

Preliminary option volume…

MOR

MorphoSys

$27.13

0.315 (1.17%)

16:28
09/25/18
09/25
16:28
09/25/18
16:28
Hot Stocks
MorphoSys says licensee has begun study to test gselkumab in pediatric group »

MorphoSys announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NITE

Nightstar Therapeutics

$20.35

-0.97 (-4.55%)

16:26
09/25/18
09/25
16:26
09/25/18
16:26
Syndicate
Nightstar Therapeutics files to sell 4M American Depositary Shares »

Jefferies, Barclays…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

NITE

Nightstar Therapeutics

$20.35

-0.97 (-4.55%)

16:24
09/25/18
09/25
16:24
09/25/18
16:24
Syndicate
Nightstar Therapeutics files to sell 4M American Depositary Shares »

Each ADS represents one…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

VSTM

Verastem

$7.15

-1.74 (-19.57%)

16:23
09/25/18
09/25
16:23
09/25/18
16:23
Hot Stocks
Breaking Hot Stocks news story on Verastem »

Verastem rises over 5%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 05

    Oct

ICCC

Immucell

$8.35

-0.155 (-1.82%)

16:22
09/25/18
09/25
16:22
09/25/18
16:22
Hot Stocks
Immucell looks to bring mastitis treatment to market in 2020 »

ImmuCell announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

ICCC

Immucell

$8.35

-0.155 (-1.82%)

16:22
09/25/18
09/25
16:22
09/25/18
16:22
Hot Stocks
Immucell receives fourth complete letter of NADA for Nisin treatment for cows »

Immucell announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

VSTM

Verastem

$7.15

-1.74 (-19.57%)

16:21
09/25/18
09/25
16:21
09/25/18
16:21
Hot Stocks
Verastem and CSPC Pharma sign license agreement to develop COPIKTRA in China »

Verastem and CSPC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 05

    Oct

LOXO

Loxo Oncology

$166.80

3.73 (2.29%)

16:21
09/25/18
09/25
16:21
09/25/18
16:21
Hot Stocks
Loxo Oncology announces LOXO-292 durability update »

Loxo Oncology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 26

    Nov

  • 27

    Nov

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
09/25/18
09/25
16:20
09/25/18
16:20
Options
Closing CBOE SPX and VIX Index summary for September 25th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$84.79

0.52 (0.62%)

16:19
09/25/18
09/25
16:19
09/25/18
16:19
Hot Stocks
Breaking Hot Stocks news story on Nike »

Nike slips 4.1% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

KBH

KB Home

$25.29

-0.24 (-0.94%)

16:19
09/25/18
09/25
16:19
09/25/18
16:19
Hot Stocks
Breaking Hot Stocks news story on KB Home »

KB Home rises over 4%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

TRN

Trinity Industries

$36.78

-0.37 (-1.00%)

16:19
09/25/18
09/25
16:19
09/25/18
16:19
Hot Stocks
Trinity Industries board approves separation of Arcosa »

Trinity Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CASH

Meta Financial

$84.15

1.45 (1.75%)

16:18
09/25/18
09/25
16:18
09/25/18
16:18
Hot Stocks
Meta Financial anounces Brent Turner will step down as EVP »

Meta Financial Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTAS

Cintas

$212.99

1.81 (0.86%)

16:18
09/25/18
09/25
16:18
09/25/18
16:18
Earnings
Cintas raises FY19 EPS view to $7.19-$7.29 from $7.00-$7.15, consensus $7.16 »

Raises FY19 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

NKE

Nike

$84.79

0.52 (0.62%)

16:18
09/25/18
09/25
16:18
09/25/18
16:18
Hot Stocks
Nike reports Q1 North America revenue $4.145B, up 6% »

Reports Q1 EMEA revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

MRCY

Mercury Systems

$53.93

1.17 (2.22%)

16:17
09/25/18
09/25
16:17
09/25/18
16:17
Hot Stocks
Mercury Systems receives $5.5M order »

Mercury Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
09/25/18
09/25
16:17
09/25/18
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.